In this review, we focus on the current studies of the MDM2–p53 axis in HCC, and specifically discuss the impact of MDM2–p53 axis dysfunction by viral infection and metabolic disease in the transformation of normal hepatocytes into hepatoma cells. This evidence concerns the gene MDM2 and hepatocellular carcinoma.